Latest News of TXG
TX Group's (VTX:TXGN) Returns On Capital Tell Us There Is Reason To Feel Uneasy
As businesses mature, declining Return on Capital Employed (ROCE) and capital employed indicate diminishing shareholder wealth. For TX Group, ROCE is at 2.0%, below the industry average of 9.3%. Despi...
10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
Adam Taich, CFO, indicated that revenue guidance cut was influenced by macroeconomic factors and internal commercial reorganization. The company expects stable gross margins with new products and aims...
TX Group's (VTX:TXGN) Earnings Are Weaker Than They Seem
Despite strong earnings, TX Group AG's stock performance was lackluster due to underlying concerns. Unusual gains contributed to profits, but may not be sustainable. Analysts' future profit forecasts ...
-
10x Genomics, Inc. (TXG): Hedge Funds Think This Stock Will Skyrocket
By Yahoo! Finance | 4 months agoA list of potential stocks with high growth potential was recently compiled, with a focus on 10x Genomics, Inc. (NASDAQ:TXG). The stock ranks 10th on the list, showing promising revenue growth accordi...
-
10x Genomics, Inc. (TXG) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 4 months ago10x Genomics, Inc. is a life science technology company offering instruments, consumables, and software for analyzing biological systems worldwide. Their products include single-cell solutions, Visium...
-
Does 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead?
By Yahoo! Finance | 4 months agoBrown Capital Management's Small Company Fund underperformed the Russell 2000 Growth index in the first quarter of 2024. Their top pick, 10x Genomics, Inc., faced challenges but showed potential. The ...